Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
10 Facts About Ophthalmologists and Their Work
Ophthalmologists, often referred to as eye doctors, are healthcare professionals who specialize in the diagnosis, treatment, and management of eye diseases and disorders. While we may visit them for routine eye exams or specific vision concerns, the world of ophthalmology…
Edenlux’s Otus Personal EYE-Trainer | OBN
The Otus personal eye-trainer, developed by Edenlux, has launched a campaign through Indiegogo. The device uses training called Vision Therapy to relieve the stress of the eyes. Vision Therapy is an exercise that repeats the contraction and relaxation of the…
Are Eye Pressure Fluctuation Normal or Cause for Concern?
Intraocular pressure (IOP) is a critical measurement in eye health, often associated with eye conditions like glaucoma. This pressure is the force exerted by the aqueous humor, the fluid inside the eye, on the ocular structures. Traditionally, eye pressure has…
Stuart Therapeutics and Glaukos’ Exclusive License Deal
Stuart Therapeutics announced that it has signed an exclusive agreement with Glaukos Corporation. In this agreement, Glaukos gains exclusive global rights to develop and market Stuart’s proprietary drug candidate, ST-113, which focuses on neuroprotection in the context of glaucoma. ST-113,…
Alimera Wraps Synchronicity Study Enrollment for Yutiq in Uveitis
Alimera Sciences has reached its enrollment target for the Synchronicity study, marking a significant milestone in the prospective, open-label clinical investigation of Yutiq (fluocinolone acetonide intravitreal implant 0.18mg). The study focuses on assessing the safety and efficacy of Yutiq in…
VSY Biotechnology Attends the 35th APACRS Congress
VSY Biotechnology participated in the 35th APACRS Congress held at the Suntec Singapore Convention & Exhibition Centre in Singapore from June 8-10, 2023. The company showcased its latest product, the AcrivaUD Trinova Pro C Pupil Adaptive® with Sinusoidal Vision Technology…
Harrow Secures US and Canadian Rights to Vevye
Harrow has recently announced a significant development by entering the prescription dry eye disease treatment market. The company has successfully struck a deal to acquire the commercial rights for Vevye (cyclosporine ophthalmic solution 0.1%) in both the United States and…
2023 Recap: Top 15 Firsts in Ophthalmology
In a year marked by groundbreaking achievements, the field of ophthalmology witnessed a series of historic firsts, pushing the boundaries of innovation and patient care. Here are the noteworthy milestones: Pioneering the integration of technology into glaucoma management, the world’s…
Top 5 Milestones in Ophthalmology History
In this article, we explore five significant milestones in the history of ophthalmology that have shaped the way we approach eye health and treatment. The ancient Egyptians, known for their advanced civilization and remarkable contributions to various fields, including medicine,…
FDA Calls for Study on Aldeyra’s Reproxalap in DED
Aldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for reproxalap, an investigational drug candidate designed for the treatment of dry eye disease.…